Sorted fractions from mouse bone marrow containing highly purified hem
opoietic stem and progenitor cells were studied for the expression of
growth factor receptors. With the use of rhodamine 123 WGA+, 15-1.1-,
low density cells were separated into quiescent pluripotent stem cells
and committed progenitor cells. RNA was extracted and cDNA was prepar
ed by reverse transcription. Using primers specific for growth factor
receptors, the cDNA of each sorted fraction was amplified by polymeras
e chain reaction (PCR). The quiescent rhodamine 123 dull stem cell fra
ction was found to express the interleukin 3 (IL-3) receptor beta unit
and c-kit, but not the granulocyte-macrophage colony stimulating fact
or (GM-CSF) receptor beta unit nor flk-2. The rhodamine 123 bright fra
ction with activated stem cells and mostly committed progenitor cells
similarly expressed the IL-3-Rbeta, and c-kit. However, this fraction
also expressed flk-2 and GM-CSF-Rbeta. Since the expression of c-kit i
n the stem cell fraction does not correspond with the poor response to
the kit-ligand stem cell factor (SCF) by these cells, we further anal
yzed the fractions with respect to their binding of biotinylated SCF.
The SCF-binding cells were found to be all rhodamine 123 bright. This
indicates that the expression of c-kit is not sufficient to yield a fu
nctional receptor for SCF; c-kit probably needs a partner molecule to
form a functional high-affinity binding site for SCF. Similar to the b
eta unit of the GM-CSF receptor, this partner is then not expressed in
the stem cell fraction. Its expression would be upregulated upon diff
erentiation and commitment. It may be speculated that this partner mol
ecule of c-kit is flk-2. Alternatively, it may be speculated that the
stem cells contain an isoform splice product of kit that has a reduced
capability for dimerization.